Eudracap Colon
EUDRACAP colon is designed for pharmaceutical products that target release in the ileo-colonic area. Like EUDRACAP enteric, it provides reliable gastric resistance to protect sensitive ingredients. However, unlike EUDRACAP enteric, which shows rapid release at pH 6.8, EUDRACAP colon offers a significantly delayed release at a higher pH. EUDRACAP colon also provides reliable protection and targeted delivery of sensitive active ingredients such as live biotherapeutics, polypeptides, and proteins (biologics) as well as nucleotides.